The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib

Abstract

The introduction of tyrosine kinase inhibitors (TKI) in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) has revolutionized the outcome, but the prognosis of the disease is still based on prognostic systems that were developed in the era of conventional chemotherapy and interferon (IFN)-alfa. A new prognostic score… (More)
DOI: 10.1038/leu.2013.171

Topics

7 Figures and Tables

Slides referencing similar topics